ISSN 2756-3340
African Journal of Infectious Diseases Research | Vol. 13, No. 11, November 2026 | pp. 996–1003
DOI: 10.46882/AJIDR/149042
Article Type: Research Article
Title: Epidemiological drivers and neutralizing antibody responses following yellow fever fractional-dose vaccination campaigns in endemic districts
Names of Authors: Babatunde Ogunleye¹*, Claire Moreau-Laurent², Kenji Sato³
Abstract: Yellow fever is a mosquito-borne viral hemorrhagic fever where vaccine supply constraints during urban outbreaks have necessitated fractional-dose immunization strategies. We evaluated long-term neutralizing antibody persistence and cellular immune responses at 24 months post-vaccination. Serum samples from 320 adults receiving one-fifth fractional doses were assayed via plaque reduction neutralization tests. Protective neutralizing antibody titers above 1:10 persisted in 93.4 percent of recipients across all age groups without serious adverse events. Fractional dosing provides durable immunity during emergency outbreak responses.
Keywords: Yellow fever virus, Fractional-dose vaccine, Neutralizing antibodies, Flavivirus immunization, Outbreak control
Citation: Ogunleye B, Moreau-Laurent C, Sato K (2026). Epidemiological drivers and neutralizing antibody responses following yellow fever fractional-dose vaccination campaigns in endemic districts. African Journal of Infectious Diseases Research, 13(11): 996–1003. DOI: 10.46882/AJIDR/149042
Manuscript Timeline: Received: October 17, 2026; Revised: November 16, 2026; Accepted: November 28, 2026; Published: November 30, 2026